is oral tirzepatide as effective as the shot Compounded Tirzepatide: Vs. Injectable Forms Oral Tirzepatide: Availability, Alternatives, and

GLP-1 therapies like Ozempic have also been shown to lower the risk of heart and kidney disease, leading to additional FDA approvals for heart and kidney protection

You focus on your health goals

Should I stop my blood pressure medication when starting tirzepatide

The predominant role of brain angiotensinogen and angiotensin in environmentally induced hypertension

These lawsuits assert legal theories, including: Trademark infringement Violating the corporate practice of medicine doctrine False advertising Unfair competition Violations of federal drug laws (misbranding, unapproved new drugs) FDA Enforcement On February 6, 2026, FDA announced its intent to use all available compliance and enforcement tools within its authorities to address unsubstantiated claims and associated public health concerns. The FDA explicitly announced steps to combat compounding pharmacies making these marketing claims: Compounded products are generic versions of FDA-approved drugs Compounded products are the same as FDA-approved drugs Compounded products use the same active ingredient as FDA-approved drugs Compounded products are clinically proven to produce results FDA has made clear that failure to adequately address any violations may result in legal action without further notice, including, without limitation, seizure and injunction. This means the agency may bypass traditional warning letter procedures